Intrinsic value of Adamis Pharmaceuticals Corporation (ADMP)

[per Chepakovich valuation model]

other valuations of ADMP

[per Chepakovich valuation model]  See other valuations of ADMP stock

Previous Close$1.02
Intrinsic Value
Upside potential
Previous Close
$1.02

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Life of production assets, yrs
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Based on fiscal year data as of 2020-12-31 and quarterly data as of 2020-12-31.
NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.
  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2020(a)2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %0.0NaN
Revenue, $17NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m66NaN
Operating income, $m-50NaN
EBITDA, $m-36NaN
Interest expense (income), $mNaN
Earnings before tax, $m-49NaN
Tax expense, $m0NaN
Net income, $m-49NaN

BALANCE SHEET

Cash and short-term investments, $m7NaN
Total assets, $m31NaN
Adjusted assets (=assets-cash), $m24NaN
Average production assets, $m18NaN
Working capital, $m-7NaN
Total debt, $m3NaN
Total liabilities, $m27NaN
Total equity, $m3NaN
Debt-to-equity ratio0.913NaN
Adjusted equity ratio-0.044NaN

CASH FLOW

Net income, $m-49NaN
Depreciation, amort., depletion, $m13NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-21NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1NaN
Free cash flow, $m-20NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-7
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN